Moderna (MRNA) PT Raised to $30 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $190.01 +0.57%
Rating Summary:
7 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
7 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ: MRNA) to $30.00 (from $29.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) call put ratio 1 call to 1.1 puts amid wide price movement
- Macquarie Upgrades Merdeka Gold Resources Tbk PT (EMAS:IJ) to Neutral
- JPMorgan Upgrades Arafura Rare Earths (ARU:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
